Modern therapies have limitations to completely cure chronic and lifestyle conditions. India’s ambition to provide universal access and quality healthcare at an affordable cost mandates a paradigm shift in adoption of Ayurveda into mainstream healthcare system.
Ayurveda’s root cause management approach goes beyond just being a curative system of medicine to being a preventive and promotive healthcare system as well. The industry has gained recognition both in India & developed countries as an alternative system of medicine. Despite having a strong advantage over modern therapies, Ayurveda industry’s growth trajectory remains subdued. There is a burning need to prioritise focus on products and services that can jump-start modest growth and triple industry’s market potential.
Frost & Sullivan and CII have partnered to undertake a Vision Roadmap study to identify mega pivots and growth levers that will unlock value in key industry segments and lead to decisive action with solid implementation. This white paper, prepared at the backdrop of the Ministry of Ayush and CII Ayurveda Conclave, is an outcome of multiple rounds of discussions with key stakeholders in the Indian Ayurveda Industry and CII leadership who have put an incredible effort into contributing to Vision Roadmap.